{"product_id":"clinical-measurement-in-drug-evaluation-hardback-9780471943914","title":"Clinical Measurement in Drug Evaluation (Hardback) 9780471943914","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eClinical Measurement in Drug Evaluation\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cfont size=\"4\"\u003eWalter S. Nimmo (Edited by), W S Nimmo (Author), Geoffrey T. Tucker (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780471943914, Wiley\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 12 April 1995\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e344 pages\u003cbr\u003e23.6 x 15.8 x 2.5 cm, 0.652 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eInternationally renowned authorities from diverse fields present the principles and practice regarding the measurement of drug effects in humans and its role in the analysis and development of new chemical entities. The main thrust is on surrogate endpoints, peripheral vascular disease, the reliability of data collection and interpretation as well as the identification, predictability and performance of drug interactions and adverse effects.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eContributors.\u003cbr\u003e \u003cbr\u003e Preface.\u003cbr\u003e \u003cbr\u003e SURROGATE ENDPOINTS AS A MEASURE OF DRUG EFFECTS.\u003cbr\u003e \u003cbr\u003e A Regulatory Authority's Opinion About Surrogate Endpoints (R.Temple).\u003cbr\u003e \u003cbr\u003e What to Measure in Dementia (L. Whalley \u0026amp; S. Gerhand).\u003cbr\u003e \u003cbr\u003e Twenty-foour-hour ambulatory arterial (blood) pressuremeasurement and the assessment of antihypertensive drug efficacy(J. Hasford, W. Meister).\u003cbr\u003e \u003cbr\u003e Potential Measurements in Patients with Osteoporosis (C.Miller).\u003cbr\u003e \u003cbr\u003e Are bronchial challenge studies indicators of antiasthmaticactivity? (A. J. Frew, S. T. Holgate)\u003cbr\u003e \u003cbr\u003e DRUGS AFFECTING BLOOD FLOW TO THE PERIPHERAL CIRCULATION.\u003cbr\u003e \u003cbr\u003e Measurements of Blood Rheology for the Evaluation ofPharmacological Agents (G. Nash).\u003cbr\u003e \u003cbr\u003e Platelet Function Tests (P. Wyld).\u003cbr\u003e \u003cbr\u003e Assessment of the Effects of Drugs on the Peripheral Vasculature(D. Webb \u0026amp; M. Hand).\u003cbr\u003e \u003cbr\u003e PRECISION, VALIDITY AND REPRODUCIBILITY OF MEASUREMENT.\u003cbr\u003e \u003cbr\u003e Bias and Confounding in Clinical Studies (D. Jones).\u003cbr\u003e \u003cbr\u003e What Does Good Clinical Practice Have to Say About ClinicalMeasurement? (E. Hvidberg).\u003cbr\u003e \u003cbr\u003e Measurement of bioequivalence and its relevance to tthe clinicalsituation (T. Salmonson)\u003cbr\u003e \u003cbr\u003e The 'Clinical Trial' of the Clinical Trial (A. Feinstein).\u003cbr\u003e \u003cbr\u003e Patient compliancewith prescribed drug regimens: overview of thepast 30 yers of research (j. Urguhart).\u003cbr\u003e \u003cbr\u003e MEASUREMENT OF ADVERSE EVENTS.\u003cbr\u003e \u003cbr\u003e Prediction of drug interactions: implications of recent advancesin drug metabolism (G. T. Tucker).\u003cbr\u003e \u003cbr\u003e What number of patients is necessary to establish drug safety?(P. R. Jackson, E. J. Wallis, W. w. Yeo, L E. Ramsay)\u003cbr\u003e \u003cbr\u003e Accuracy of adverse data from post-marketing studies and theinfluence on extension of licensed indications (D. H.Lawson).\u003cbr\u003e \u003cbr\u003e Controlled Clinical Trials: Contribution to Drug Safety (M.Langman).\u003cbr\u003e \u003cbr\u003e Predicting Adverse Drug Reactions (C. George).\u003cbr\u003e \u003cbr\u003e THE EDINBURGH DRUG ABSORPTION FOUNDATION LECTURE.\u003cbr\u003e \u003cbr\u003e Interactions in First-Pass Metabolism and Variability in DrugResponse (P. Neuvonen).\u003cbr\u003e \u003cbr\u003e Index.\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Other branches of medicine [\u003ca title=\"See our other books on Other branches of medicine\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Other%20branches%20of%20medicine%20%5BMM%5D%22\"\u003eMM\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Wiley","offers":[{"title":"Brand New","offer_id":52298074587416,"sku":"9780471943914","price":318.96,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/files\/9780471943914.jpg?v=1781734739","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/clinical-measurement-in-drug-evaluation-hardback-9780471943914","provider":"Freshly Printed Books","version":"1.0","type":"link"}